Welcome to LookChem.com Sign In|Join Free
  • or
4-Phenoxyphenylthiourea, with the molecular formula C13H12N2OS, is a urea derivative featuring a thiourea group attached to a benzene ring that is substituted with a phenoxy group. This chemical compound is known for its role in organic synthesis and research, where it serves as a reagent for the synthesis of various organic compounds.

76839-21-9

Post Buying Request

76839-21-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

76839-21-9 Usage

Uses

Used in Organic Synthesis:
4-Phenoxyphenylthiourea is used as a reagent in organic synthesis for the production of a range of organic compounds. Its unique structure allows it to participate in various chemical reactions, facilitating the creation of new molecules with potential applications across different industries.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4-Phenoxyphenylthiourea is being studied for its potential applications, including its inhibitory effects on several enzymes. This property makes it a candidate for the development of new drugs targeting specific enzymatic pathways related to various diseases.
Used in Agricultural Research:
4-Phenoxyphenylthiourea has been investigated for its potential use in agriculture as a plant growth regulator. Its effects on plant development are of interest to researchers looking to enhance crop yields and improve resistance to environmental stressors.
Used in Agrochemical Development:
Additionally, 4-phenoxyphenylthiourea is being explored for its potential in the production of herbicides and pesticides. 4-PHENOXYPHENYLTHIOUREA's ability to regulate plant growth and its effects on enzymatic processes could be harnessed to control unwanted plant species or protect crops from pests, although its application in this area is still in the research and development stage.

Check Digit Verification of cas no

The CAS Registry Mumber 76839-21-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,8,3 and 9 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 76839-21:
(7*7)+(6*6)+(5*8)+(4*3)+(3*9)+(2*2)+(1*1)=169
169 % 10 = 9
So 76839-21-9 is a valid CAS Registry Number.
InChI:InChI=1/C13H12N2OS/c14-13(17)15-10-6-8-12(9-7-10)16-11-4-2-1-3-5-11/h1-9H,(H3,14,15,17)

76839-21-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (L11804)  N-(4-Phenoxyphenyl)thiourea, 96%   

  • 76839-21-9

  • 1g

  • 410.0CNY

  • Detail
  • Alfa Aesar

  • (L11804)  N-(4-Phenoxyphenyl)thiourea, 96%   

  • 76839-21-9

  • 5g

  • 1571.0CNY

  • Detail

76839-21-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(4-Phenoxyphenyl)thiourea

1.2 Other means of identification

Product number -
Other names (4-phenoxyphenyl)thiourea

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:76839-21-9 SDS

76839-21-9Relevant academic research and scientific papers

The synthesis of 2-amino-4(3H)-quinazolinones and related heterocycles via a mild electrocyclization of aryl guanidines

Sales, Zachary S.,Mani, Neelakandha S.,Allison, Brett D.

supporting information, p. 1623 - 1626 (2018/03/29)

A new method for the preparation of 2-amino-4(3H)-quinazolinones and similar fused heterocycles is described. Simply warming a mixture of an aryl guanidine and carbonyl diimidazole in acetonitrile results in formation of a putative N-amidinoisocyanate intermediate which undergoes a 6π-electron electrocyclic reaction with the aryl ring to generate the quinazolinone ring system. The mild conditions are compatible with a variety of functional groups, and the reaction is shown to be successful on multigram scale.

Synthesis and antimicrobial activity of structurally flexible heterocycles with the 1,4-thiazine heterosystem

Sharma, Praveen Kumar,Fogla, Ankur,Rathore,Kumar

experimental part, p. 1103 - 1111 (2012/04/17)

In this work, 4H-1,4-benzothiazines were synthesized by an efficient synthetic method in a single step involving heterocyclization of substituted 2-aminobenzenethiols with β-ketoester. The structures of the synthesized compounds were confirmed by their analytical and spectral data. The synthesized compounds were evaluated for their antimicrobial activity against bacterial species; E. coli and Bacillus cereus. The synthesized compounds showed significant activity against microorganisms, which can be correlated with the privileged heterocyclic structural scaffolds.

Design, synthesis, cytoselective toxicity, structure-activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistant lung cancer cells

Zhou, Hongyu,Wu, Shuhong,Zhai, Shumei,Liu, Aifeng,Sun, Ying,Li, Rongshi,Zhang, Ying,Ekins, Sean,Swaan, Peter W.,Fang, Bingliang,Zhang, Bin,Yan, Bing

, p. 1242 - 1251 (2008/12/23)

Ten cytoselective compounds have been identified from 372 thiazolidinone analogues by applying iterative library approaches. These compounds selectively killed both non-small cell lung cancer cell line H460 and its paclitaxel-resistant variant H460taxR at an IC50 between 0.21 and 2.93 μM while showing much less toxicity to normal human fibroblasts at concentrations up to 195 μM. Structure-activity relationship studies revealed that (1) the nitrogen atom on the 4-thiazolidinone ring (ring B in Figure 1) cannot be substituted, (2) several substitutions on ring A are tolerated at various positions, and (3) the substitution on ring C is restricted to the -NMe2 group at the 4-position. A pharmacophore derived from active molecules suggested that two hydrogen bond acceptors and three hydrophobic regions were common features. Activities against P-gp-overexpressing and paclitaxel-resistant cell line H460taxR and modeling using a previously validated P-gp substrate pharmacophore suggested that active compounds were not likely P-gp substrates.

SUBSTITUTED ARYLTHIOUREA DERIVATIVES USEFUL AS INHIBITORS OF VIRAL REPLICATION

-

Page/Page column 42, (2010/02/10)

Substituted arylthiourea compounds of Formula I, and the pharmaceutically acceptable salts of such compounds, useful as antiviral agents, are provided herein. Certain substituted arylthioureas disclosed herein are potent and/ or selective inhibitors of viral replication, particularly Hepatitis C virus replication. Pharmaceutical compositions containing one or more substituted arylthiourea compounds and one or more pharmaceutically acceptable carriers, excipients, or diluents are provided herein. Such pharmaceutical compositions may contain a substituted arylthiourea as the only active agent or may contain a combination of a substituted arylthiourea derivative and one or more other pharmaceutically active agents. Methods of treating Hepatitis C viral infections in mammals are also provided herein.

Synthesis of thiophene-2-carboxamidines containing 2-aminothiazoles and their biological evaluation as urokinase inhibitors

Wilson, Kenneth J.,Illig, Carl R.,Subasinghe, Nalin,Hoffman, James B.,Jonathan Rudolph,Soll, Richard,Molloy, Christopher J.,Bone, Roger,Green, David,Randall, Troy,Zhang, Marie,Lewandowski, Frank A.,Zhou, Zhao,Sharp, Celia,Maguire, Diane,Grasberger, Bruce,DesJarlais, Renee L.,Spurlino, John

, p. 915 - 918 (2007/10/03)

The serine protease urokinase (uPa) has been implicated in the progression of both breast and prostate cancer. Utilizing structure based design, the synthesis of a series of substituted 4-[2-amino-1,3-thiazolyl]-thiophene-2-carboxamidines is described. Further optimization of this series by substitution of the terminal amine yielded urokinase inhibitors with excellent activities.

Substituted N-phenylisothioureas: Potent inhibitors of human nitric oxide synthase with neuronal isoform selectivity

Shearer, Barry G.,Lee, Shuliang,Oplinger, Jeffrey A.,Frick, Lloyd W.,Garvey, Edward P.,Furfine, Eric S.

, p. 1901 - 1905 (2007/10/03)

S-Ethyl N-phenylisothiourea (4) has been found to be a potent inhibitor of both the human constitutive and inducible isoforms of nitric oxide synthase. A series of substituted N-phenylisothiourea analogues was synthesized to investigate the structure-activity relationship of this class of inhibitor. Each analogue was evaluated for human isoform selectivity. One analogue, S-ethyl N-[4-(trifluoromethyl)phenyl]isothiourea (39), exhibited 115-fold and 29-fold selectivity for the neuronal isoform versus the inducible and endothelial derived constitutive isoforms, respectively. Studies have shown the substituted N-phenylisothiourea 39 binds competitively with L,-arginine.

Benzothiazol-2-one-3-alkanoic acids and esters and aldose reductase inhibiting compositions thereof

-

, (2008/06/13)

A pharmaceutical composition comprising certain benzothiazoline alkanoic acid derivatives for the prevention and treatment of various diabetic complications, said derivatives being inhibitors of aldose reductase.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 76839-21-9